Mayinglong Pharmaceutical Group Co (SHSE:600993) Cyclically Adjusted FCF per Share: ¥0.88 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600993 Mayinglong Pharmaceutical Group Co Ltd SHSE:600993
93 GF Score
Price ¥24.01
GF Value ¥29.63
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Mayinglong Pharmaceutical Group Co Cyclically Adjusted FCF per Share?

Mayinglong Pharmaceutical Group Co SHSE:600993 +2.52% 93 Cyclically Adjusted FCF per Share is ¥0.88 as of Mar. 2026. GuruFocus rates SHSE:600993 with a GF Score™ of 93/100 and a GF Value™ of ¥29.63 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Mayinglong Pharmaceutical Group Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥0.511. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.88 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Mayinglong Pharmaceutical Group Co's average Cyclically Adjusted FCF Growth Rate was 15.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 12.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 13.00% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 19.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Mayinglong Pharmaceutical Group Co was 29.80% per year. The lowest was 4.60% per year. And the median was 19.40% per year.

As of today (2026-07-28), Mayinglong Pharmaceutical Group Co's current stock price is ¥24.01. Mayinglong Pharmaceutical Group Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥0.88. Mayinglong Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF of today is 27.28.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Mayinglong Pharmaceutical Group Co was 169.23. The lowest was 24.49. And the median was 46.97.


Mayinglong Pharmaceutical Group Co  (SHSE:600993) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Mayinglong Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=24.01/0.88
=27.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Mayinglong Pharmaceutical Group Co was 169.23. The lowest was 24.49. And the median was 46.97.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Mayinglong Pharmaceutical Group Co Cyclically Adjusted FCF per Share Related Terms


Mayinglong Pharmaceutical Group Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Mayinglong Pharmaceutical Group Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mayinglong Pharmaceutical Group Co Cyclically Adjusted FCF per Share Chart

Mayinglong Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.55 0.58 0.65 0.72 0.82

Mayinglong Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 0.78 0.82 0.82 0.88

SHSE:600993 vs ZTS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Mayinglong Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mayinglong Pharmaceutical Group Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mayinglong Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Mayinglong Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:600993
93GF Score
Mayinglong Pharmaceutical Group Co Ltd SHSE:600993
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mayinglong Pharmaceutical Group Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mayinglong Pharmaceutical Group Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.511/116.3033*116.3033
=0.511

Current CPI (Mar. 2026) = 116.3033.

Mayinglong Pharmaceutical Group Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.003 101.400 0.003
201609 0.308 102.400 0.350
201612 0.121 102.600 0.137
201703 0.114 103.200 0.128
201706 0.190 103.100 0.214
201709 0.203 104.100 0.227
201712 0.222 104.500 0.247
201803 -0.117 105.300 -0.129
201806 0.023 104.900 0.026
201809 0.510 106.600 0.556
201812 0.219 106.500 0.239
201903 0.051 107.700 0.055
201906 -0.002 107.700 -0.002
201909 0.179 109.800 0.190
201912 0.828 111.200 0.866
202003 0.004 112.300 0.004
202006 0.281 110.400 0.296
202009 0.428 111.700 0.446
202012 -0.152 111.500 -0.159
202103 -0.332 112.662 -0.343
202106 0.029 111.769 0.030
202109 0.639 112.215 0.662
202112 0.913 113.108 0.939
202203 -0.359 114.335 -0.365
202206 0.087 114.558 0.088
202209 0.782 115.339 0.789
202212 0.120 115.116 0.121
202303 -0.317 115.116 -0.320
202306 0.050 114.558 0.051
202309 0.174 115.339 0.175
202312 0.922 114.781 0.934
202403 0.015 115.227 0.015
202406 0.290 114.781 0.294
202409 0.047 115.785 0.047
202412 0.333 114.893 0.337
202503 0.246 115.116 0.249
202506 0.343 114.907 0.347
202509 0.349 115.471 0.352
202512 0.177 115.832 0.178
202603 0.511 116.303 0.511

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.88 mean?
Mayinglong Pharmaceutical Group Co (SHSE:600993) has a Cyclically Adjusted FCF per Share of ¥0.88 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Mayinglong Pharmaceutical Group Co and its competitors.
Is Mayinglong Pharmaceutical Group Co's Cyclically Adjusted FCF per Share too high?
Mayinglong Pharmaceutical Group Co's current Cyclically Adjusted FCF per Share is ¥0.88. Overall, Mayinglong Pharmaceutical Group Co has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mayinglong Pharmaceutical Group Co's Cyclically Adjusted FCF per Share compare to ZTS?
Mayinglong Pharmaceutical Group Co's Cyclically Adjusted FCF per Share of ¥0.88 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Mayinglong Pharmaceutical Group Co and its competitors. Mayinglong Pharmaceutical Group Co's current Cyclically Adjusted FCF per Share is ¥0.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mayinglong Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Mayinglong Pharmaceutical Group Co (SHSE:600993) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥29.63, compared to a current price of ¥24.01 — trading 19% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.88. Mayinglong Pharmaceutical Group Co's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Mayinglong Pharmaceutical Group Co (SHSE:600993), the current Cyclically Adjusted FCF per Share is ¥0.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mayinglong Pharmaceutical Group Co (SHSE:600993) Overvalued in 2026?

Based on GuruFocus' analysis, Mayinglong Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥24.01 is trading 19% below its estimated GF Value™ of ¥29.63. GuruFocus considers Mayinglong Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:600993:

  • Cyclically Adjusted FCF per Share: ¥0.88
  • GF Value™: ¥29.63 vs. price of ¥24.01 (19% below fair value)
  • GF Score™: 93/100 with 1 warning sign

No single metric tells the full story. See the SHSE:600993 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mayinglong Pharmaceutical Group Co Business Description

Address No. 100 Zhoujiawan, Nanhu, Wuchang District, Wuhan, Hubei, CHN, 430064
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly involved in pharmaceutical development, retailing and wholesaling. The company provides ointments, suppositories, and tablets for hemorrhoids.
93GF Score

Get the complete analysis for SHSE:600993

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥24.01
Price
¥29.63
GF Value